Sign up for our newsletter and get
updates in your inbox.
By Rhonda Reinhart
In recent news, the Michael J. Fox Foundation offered a $1.5 million grant to an Austrian pharmaceutical company to help fund research into a vaccine …
By John Lugo
A vaccine for Parkinson’s disease has shown promising results in a Phase 1 clinical trial and will soon undergo a follow-up study.
The drug, known as …